Titomic Limited (ASX:TTT) Share Price Declines as Investors Track Manufacturing Expansion and Commercial Progress

Anjali Anand

12 August 2026 07:48 PM AEST

Titomic Limited (ASX:TTT) Share Price Declines as Investors Track Manufacturing Expansion and Commercial Progress

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Titomic Limited (ASX:TTT) closed at A$0.170 on 12 August 2026, declining 2.857% from the previous close.
The company continues developing cold-spray additive Manufacturing technology for industrial applications.
Titomic is progressing activities associated with its United States manufacturing expansion.
The company has been focused on converting technology development activities into commercial opportunities.
Market attention remains focused on contract progress, funding requirements and commercialisation milestones.

Titomic Limited (ASX:TTT) closed at A$0.170 on 12 August 2026, declining A$0.004 or 2.857% from the previous close of A$0.175. Trading Volume reached 403,818 shares, while the stock recorded an intraday range of A$0.165 to A$0.175. The company’s Market Capitalisation stood at A$281.31M, with 1,607,530,316 shares on issue.

The share price movement occurred as investors continued monitoring Titomic’s commercial development activities, manufacturing expansion plans and progress in converting its technology platform into Revenue opportunities.

Cold Spray Manufacturing Technology Remains Central Focus

Titomic Limited is focused on cold-spray additive manufacturing technology, which uses metal powders to produce components without conventional melting processes. The company’s technology is designed for applications requiring metal component production and repair capabilities.

The company has been developing its manufacturing capabilities and expanding its presence in the United States market. Its activities include building capacity in Huntsville, Alabama, and progressing plans related to its United States corporate structure.

United States Expansion and Commercial Development

Titomic has been focused on positioning its technology closer to potential customers in the United States. The company’s expansion activities are aimed at supporting access to industrial and defence-related manufacturing opportunities.

The company has highlighted the potential applications of cold-spray technology in producing and repairing metal parts. These capabilities are being evaluated as part of its broader commercialisation strategy.

Progress in converting technology interest into recurring commercial activity remains an important area monitored by investors.

Contract Activity and Manufacturing Applications

Titomic has reported commercial development activity through contracts associated with its manufacturing technology. The company secured an Early Manufacturing Development contract valued at approximately US$1.7 million, or around A$2.55 million, to produce defence-related articles using its cold-spray technology at Huntsville.

The contract represents an application of the company’s manufacturing capability, while future progress depends on the company’s ability to develop additional commercial opportunities and production activities.

Commercialisation Stage and Funding Considerations

Titomic remains in a commercialisation phase, with ongoing Investment required for equipment, facilities and United States expansion activities. The company has previously raised capital through Equity issuance to support these initiatives.

The company’s future funding requirements remain an important consideration as it continues developing operations and pursuing additional commercial opportunities.

Corporate Development and Redomiciliation Plans

Titomic has been progressing a proposed United States redomiciliation scheme as part of its broader corporate strategy. The company confirmed that the process remained on track, with a revised timetable indicated during 2026.

The company’s corporate structure changes and international expansion activities remain areas monitored alongside operational developments.

Key Factors Influencing Future Performance

Future developments for Titomic are expected to depend on several factors, including contract progression, commercial order activity, manufacturing capability development and funding requirements.

The company’s ability to increase revenue from its technology platform remains an important consideration. Defence and industrial manufacturing programs can involve extended development timelines, making contract conversion and production activity key areas of focus.

Outlook for Titomic

Titomic is expected to continue focusing on advancing its cold-spray manufacturing technology, United States expansion activities and commercial development initiatives. The company’s future progress will depend on additional contract opportunities, manufacturing execution and the development of Recurring Revenue sources.

Market attention is expected to remain focused on updates relating to customer programs, corporate milestones and operational funding requirements.

Conclusion

Titomic Limited (ASX:TTT) continues to operate through a commercialisation phase focused on advancing cold-spray additive manufacturing technology and expanding its manufacturing capabilities. The company has progressed contract activity, United States expansion plans and technology development initiatives. However, future performance will depend on converting these activities into sustained commercial outcomes while managing funding requirements. The share price movement on 12 August 2026 reflects ongoing market assessment of the company’s progress and future milestones.

FAQs

Q: What was Titomic Limited’s (ASX:TTT) closing share price on 12 August 2026?

A:Titomic Limited (ASX:TTT) closed at A$0.170 on 12 August 2026, down A$0.004 or 2.857% from the previous close.

Q: What technology does Titomic develop?

A:Titomic develops cold-spray additive manufacturing technology that uses metal powders to produce components without conventional melting processes.

Q: What is Titomic’s focus in the United States?

A:Titomic has been developing manufacturing capacity in the United States and progressing activities related to its corporate expansion strategy.

Q: Has Titomic secured commercial contracts?

A:The company has reported an Early Manufacturing Development contract valued at approximately US$1.7 million, or around A$2.55 million, related to production using its cold-spray technology.

Q: What are the key factors to monitor for Titomic?

A:Key factors include contract developments, commercialisation progress, manufacturing capability, funding requirements and future operational milestones.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.